Electroencephalography has long been central to neurological diagnosis, yet some of its most powerful analytical capabilities have historically been underused.
EEG source localization is one of them. While the ability to estimate where electrical activity originates in the brain has existed for years, it has often lived outside routine EEG workflows, reserved for research environments, specialized centers, or a small subset of complex cases.
The limitation lies in access.
Advanced source localization tools typically require separate software, additional licenses, and non-trivial workflow steps. As a result, many EEG studies are reviewed without spatial context, even when localization data could deepen understanding or inform next steps.
At LVIS Corporation, our product NeuroMatch® changes that model. By embedding EEG source localization directly into routine EEG review, NeuroMatch makes spatial insight available for every study, without added complexity, cost barriers, or workflow disruption.
The Clinical Value of EEG Source Localization
Traditional EEG interpretation focuses on waveforms: amplitude, frequency, morphology, and timing. These features remain essential, but they describe what is happening more than where it is happening.
EEG source localization adds spatial context to electrophysiological data. Through the estimation of cortical regions most likely generating observed signals, clinicians gain an additional dimension of insight. This can clarify seizure onset zones, characterize network behavior, and support more informed clinical reasoning.
Spatial information is particularly valuable in epilepsy care, where seizure semiology, patient-reported symptoms, and scalp EEG findings do not always align cleanly. In fact, a routine EEG’s sensitivity at detecting interictal epileptiform discharges can be as low as 20% to 50% in single short recordings, which means many epilepsy cases cannot be confirmed on a first EEG alone.
Seeing electrical activity mapped onto a three-dimensional brain model can help clinicians connect waveform patterns with anatomical regions, improving interpretive confidence.
Just as importantly, access to localization during review (not as a post-processing step) supports efficiency. When spatial insight is immediately available, clinicians can evaluate findings holistically rather than revisiting cases later or relying on secondary analyses performed outside the primary EEG workflow.
Traditionally Cost- and Workflow-Prohibitive—But No Longer
Despite its clinical value, EEG source localization has often remained underutilized due to practical constraints rather than scientific limitations.
Historically, implementation has required:
- Separate software licenses outside the EEG reader
- Exporting and importing data between platforms
- Additional training and limited user access
- Selective use only for certain cases or providers
These barriers mean that localization is frequently applied inconsistently. It’s available to some clinicians, some studies, or some institutions, but not others.
In many care settings, the majority of EEGs never receive spatial analysis, even when it could meaningfully contribute to interpretation.
When advanced tools sit outside standard workflows, they tend to become exceptions rather than norms. NeuroMatch® was designed to remove that friction.
Seizure Source Localization in Practice
Within NeuroMatch®, seizure source localization is presented in clinician-focused terms that align with how EEGs are actually reviewed.
Detected or user-annotated seizure events can be mapped directly onto a three-dimensional brain model, allowing clinicians to visualize where activity is most likely originating. Across multiple events, spatial patterns can be reviewed collectively, supporting a more complete understanding of seizure behavior over time.
This capability supports several clinically relevant activities:
- Diagnostic discovery, especially in patients with complex or refractory epilepsy
- Correlation of patient-reported symptoms with specific brain regions
- Supporting surgical or neurostimulation considerations, including VNS and RNS
The key distinction is availability. This insight is not reserved for select cases or specialized workflows. Instead, it is accessible during routine EEG review, making spatial analysis a consistent part of clinical interpretation rather than an occasional add-on.
Source Localization for Every Study, Built Directly Into NeuroMatch®
NeuroMatch® integrates EEG source localization directly into the EEG reader itself. There is no external software to manage, no secondary licenses to track, and no interruption to established review processes.
For clinical teams, this built-in access means:
- Faster EEG review without workflow handoffs
- Consistent availability across clinicians and care teams
- The ability to consider spatial context for every EEG, not just high-complexity cases
When advanced analysis is part of the same environment used for waveform review, it becomes easier to apply routinely. Over time, this consistency supports higher throughput and more uniform interpretation standards across organizations.
FDA Clearance as the Foundation for Broad Clinical Access
NeuroMatch is FDA-cleared, reflecting our commitment at LVIS Corporation to building tools that meet regulatory standards for clinical use.
NeuroMatchprovides the foundation for confident, consistent application of source localization.NeuroMatchcan be used as part of routine care, which supports broader adoption within clinical environments.
How NeuroMatch® Supports Deeper EEG Review
Source localization in NeuroMatch® is part of a broader ecosystem designed to support efficient, high-quality EEG interpretation.
Key capabilities include:
- Browser-based access, reducing system and location constraints
- Artifact reduction, improving signal clarity prior to spatial analysis
- AI-assisted detection and trending, complementing clinician review
- Unified reporting, keeping waveform findings, spatial insights, and annotations consolidated
Together, these features support deeper review without adding complexity. This helps clinicians focus on interpretation rather than tool management.
Reframing Advanced EEG Tools as the New Standard
As neurological care continues to evolve, advanced analytical capabilities are no longer niche. Consistent access to spatial insight supports equity in assessment, reduces variability between providers, and aligns EEG review with modern expectations for data-driven clinical decision-making.
EEG source localization does not need to remain an elite or occasional tool. When integrated directly into routine workflows, it becomes a natural extension of modern EEG interpretation, supporting better understanding without increasing burden.
The result is more consistent, informed patient care.
See Source Localization in Action Within Your EEG Workflow
NeuroMatch® brings EEG source localization into everyday clinical practice by embedding it directly into routine EEG review. With built-in access, FDA clearance, and workflow-aligned design, spatial insight becomes available for every study.To see how integrated source localization fits into real EEG workflows, schedule a NeuroMatch® demo and experience how deeper insight can be part of every review.